{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T17:29:51Z","timestamp":1783531791809,"version":"3.55.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.humimm.2023.110741","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T18:01:35Z","timestamp":1702404095000},"page":"110741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The elevation of plasma galectin-9 levels in patients with psoriasis and its associations with inflammatory and immune checkpoint molecules in skin tissues"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0771-6071","authenticated-orcid":false,"given":"Haorile","family":"Chagan-Yasutan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagongbilige","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarnai","family":"Arlud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5489-0489","authenticated-orcid":false,"given":"Jun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0947-7625","authenticated-orcid":false,"given":"Toshio","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9997","key":"10.1016\/j.humimm.2023.110741_b0005","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2023.110741_b0010","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.82","article-title":"Psoriasis","volume":"2","author":"Greb","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.humimm.2023.110741_b0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028116","article-title":"Prevalence and characteristics of psoriasis in Denmark: findings from the Danish skin cohort","volume":"9","author":"Egeberg","year":"2019","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.humimm.2023.110741_b0020","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/jdv.15762","article-title":"Incidence and prevalence of psoriasis in Israel between 2011 and 2017","volume":"33","author":"Schonmann","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"5","key":"10.1016\/j.humimm.2023.110741_b0025","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.humimm.2023.110741_b0030","first-page":"718","article-title":"Cardiovascular comorbidity in psoriasis - psoriatic inflammation is more than just skin deep","volume":"21","author":"Kommoss","year":"2023","journal-title":"J. Dtsch. Dermatol. Ges."},{"issue":"3","key":"10.1016\/j.humimm.2023.110741_b0035","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00281-019-00742-7","article-title":"T cell pathology in skin inflammation","volume":"41","author":"Sabat","year":"2019","journal-title":"Semin. Immunopathol."},{"issue":"10275","key":"10.1016\/j.humimm.2023.110741_b0040","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.humimm.2023.110741_b0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2020.05.008","article-title":"The current landscape of psoriasis genetics in 2020","volume":"99","author":"Ogawa","year":"2020","journal-title":"J. Dermatol. Sci."},{"issue":"2","key":"10.1016\/j.humimm.2023.110741_b0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/511051","article-title":"A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes","volume":"80","author":"Cargill","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.humimm.2023.110741_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01549","article-title":"The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis","volume":"9","author":"Albanesi","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2023.110741_b0060","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1189\/jlb.1213633","article-title":"Th17 cells and Tregs: unlikely allies","volume":"95","author":"Chen","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.humimm.2023.110741_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01764","article-title":"Adaptive and innate immunity in psoriasis and other inflammatory disorders","volume":"10","author":"Schon","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2023.110741_b0070","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jcv.2013.10.022","article-title":"Galectin-9 plasma levels reflect adverse hematological and immunological features in acute dengue virus infection","volume":"58","author":"Chagan-Yasutan","year":"2013","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.humimm.2023.110741_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2021.104287","article-title":"Galectin-9 as a biomarker of disease severity","volume":"361","author":"Moar","year":"2021","journal-title":"Cell. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2023.110741_b0080","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.immuni.2014.06.011","article-title":"Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells","volume":"41","author":"Wu","year":"2014","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.humimm.2023.110741_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048574","article-title":"Cell surface galectin-9 expressing Th cells regulate Th17 and Foxp3+ Treg development by galectin-9 secretion","volume":"7","author":"Oomizu","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.humimm.2023.110741_b0090","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nm.2422","article-title":"Protective HIV-specific CD8+ T cells evade Treg cell suppression","volume":"17","author":"Elahi","year":"2011","journal-title":"Nat. Med."},{"issue":"6871","key":"10.1016\/j.humimm.2023.110741_b0095","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/415536a","article-title":"Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease","volume":"415","author":"Monney","year":"2002","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.humimm.2023.110741_b0100","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1182\/blood-2010-10-310425","article-title":"Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia","volume":"117","author":"Zhou","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.humimm.2023.110741_b0105","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.humimm.2023.110741_b0110","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2340\/00015555-1285","article-title":"Impaired expression of Tim-3 on Th17 and Th1 cells in psoriasis","volume":"92","author":"Kanai","year":"2012","journal-title":"Acta Derm. Venereol."},{"issue":"2","key":"10.1016\/j.humimm.2023.110741_b0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/path.3996","article-title":"Psoriasis in humans is associated with down-regulation of galectins in dendritic cells","volume":"228","author":"de la Fuente","year":"2012","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.humimm.2023.110741_b0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.4103\/ijdvl.IJDVL_252_18","article-title":"Serum galectin-9 levels in atopic dermatitis, psoriasis and allergic contact dermatitis: a cross-sectional study","volume":"85","author":"Nofal","year":"2019","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"issue":"12","key":"10.1016\/j.humimm.2023.110741_b0125","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1398-9995.2006.01130.x","article-title":"Regulatory mechanisms of galectin-9 and eotaxin-3 synthesis in epidermal keratinocytes: possible involvement of galectin-9 in dermal eosinophilia of Th1-polarized skin inflammation","volume":"61","author":"Igawa","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.humimm.2023.110741_b0130","unstructured":"Association, P.C.o.D.a.V.b.o.C.M., Guideline for the diagnosis and treatment of psoriasis in China (2018 simplified edition). Chin. J. Dermatol. 052.004 (2019) 223\u2013230."},{"key":"10.1016\/j.humimm.2023.110741_b0135","article-title":"Tim-3 expression causes NK cell dysfunction in type 2 diabetes patients","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2023.110741_b0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-08277-5","article-title":"Hematopoietic PBX-interacting protein mediates cartilage degeneration during the pathogenesis of osteoarthritis","volume":"10","author":"Ji","year":"2019","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.humimm.2023.110741_b0145","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1136\/gutjnl-2019-318912","article-title":"Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas","volume":"68","author":"Zhang","year":"2019","journal-title":"Gut"},{"issue":"15","key":"10.1016\/j.humimm.2023.110741_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158076","article-title":"Mast cell cytokines IL-1, IL-33, and IL-36 Mediate skin inflammation in psoriasis: a novel therapeutic approach with the anti-inflammatory cytokines IL-37, IL-38, and IL-1Ra","volume":"22","author":"Conti","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2023.110741_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.667690","article-title":"Exploring the pathogenesis of psoriasis complicated with atherosclerosis via microarray data analysis","volume":"12","author":"Su","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2023.110741_b0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nri.2017.112","article-title":"Immune checkpoint blockade in infectious diseases","volume":"18","author":"Wykes","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.humimm.2023.110741_b0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02354","article-title":"The rise of NK cell checkpoints as promising therapeutic targets in cancer immunotherapy","volume":"10","author":"Sun","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2023.110741_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153485","article-title":"Immune checkpoints and cancer development: therapeutic implications and future directions","volume":"223","author":"Mehdizadeh","year":"2021","journal-title":"Pathol. Res. Pract."},{"issue":"4","key":"10.1016\/j.humimm.2023.110741_b0175","first-page":"654","article-title":"Expression of Galectin-9 and correlation with disease activity and vascular endothelial growth factor in rheumatoid arthritis","volume":"38","author":"Wang","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.humimm.2023.110741_b0180","article-title":"Galectin-9 expression correlates with therapeutic effect in rheumatoid arthritis","volume":"11","author":"Sun","year":"2021","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.humimm.2023.110741_b0185","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1089\/aid.2014.0004","article-title":"Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers","volume":"30","author":"Tandon","year":"2014","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"3","key":"10.1016\/j.humimm.2023.110741_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/biom11030430","article-title":"Blood levels of galectin-9, an immuno-regulating molecule, reflect the severity for the acute and chronic infectious diseases","volume":"11","author":"Iwasaki-Hozumi","year":"2021","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.humimm.2023.110741_b0195","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.clim.2009.04.012","article-title":"Stable form of galectin-9, a Tim-3 ligand, inhibits contact hypersensitivity and psoriatic reactions: a potent therapeutic tool for Th1- and\/or Th17-mediated skin inflammation","volume":"132","author":"Niwa","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.humimm.2023.110741_b0200","article-title":"Exploring the association and causal effect between white blood cells and psoriasis using large-scale population data","volume":"14","author":"Zhou","year":"2023","journal-title":"Front. Immunol."},{"issue":"Suppl 1","key":"10.1016\/j.humimm.2023.110741_b0205","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000053623","article-title":"Ecalectin\/galectin-9, a novel eosinophil chemoattractant: its function and production","volume":"122","author":"Hirashima","year":"2000","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.humimm.2023.110741_b0210","doi-asserted-by":"crossref","DOI":"10.1186\/1476-7961-8-12","article-title":"The increase of plasma galectin-9 in a patient with insulin allergy: a case report","volume":"8","author":"Chagan-Yasutan","year":"2010","journal-title":"Clin. Mol. Allergy"},{"issue":"1","key":"10.1016\/j.humimm.2023.110741_b0215","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13756-4","article-title":"Neutrophil extracellular trap-associated RNA and LL37 enable self-amplifying inflammation in psoriasis","volume":"11","author":"Herster","year":"2020","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.humimm.2023.110741_b0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001387","article-title":"Neutrophils promote T-cell activation through the regulated release of CD44-bound Galectin-9 from the cell surface during HIV infection","volume":"19","author":"Dunsmore","year":"2021","journal-title":"PLoS Biol."},{"issue":"12","key":"10.1016\/j.humimm.2023.110741_b0225","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1093\/rheumatology\/keab608","article-title":"Gout presenting as a chronic inflammatory arthritis from immune checkpoint inhibitors: case series","volume":"60","author":"Lee","year":"2021","journal-title":"Rheumatol. (Oxford)"},{"issue":"3","key":"10.1016\/j.humimm.2023.110741_b0230","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00384-21","article-title":"Galectin-9, a player in cytokine release syndrome and a surrogate diagnostic biomarker in SARS-CoV-2 infection","volume":"12","author":"Bozorgmehr","year":"2021","journal-title":"MBio"},{"key":"10.1016\/j.humimm.2023.110741_b0235","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.20090","article-title":"Signaling of multiple IL-17 family cytokines through IL-17RA drive psoriasis-related inflammatory pathways","author":"Tollenaere","year":"2021","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.humimm.2023.110741_b0240","first-page":"119","article-title":"Interleukin 10 promotor gene polymorphism in the pathogenesis of psoriasis","volume":"28","author":"Isac","year":"2019","journal-title":"Acta Dermatoven. Alp Pannonica Adriat"},{"issue":"6","key":"10.1016\/j.humimm.2023.110741_b0245","doi-asserted-by":"crossref","first-page":"9111","DOI":"10.3892\/mmr.2017.7719","article-title":"Regulation of M1-type and M2-type macrophage polarization in RAW264.7 cells by Galectin-9","volume":"16","author":"Lv","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.humimm.2023.110741_b0250","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/imm.13539","article-title":"Characterization of the immune regulatory property of CD22(+) CD9(+) B cells","volume":"167","author":"Yang","year":"2022","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.humimm.2023.110741_b0255","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.4049\/jimmunol.1901114","article-title":"Intracellular galectin-9 enhances proximal TCR signaling and potentiates autoimmune diseases","volume":"204","author":"Chen","year":"2020","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.humimm.2023.110741_b0260","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1038\/jid.2014.28","article-title":"Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms","volume":"134","author":"Li","year":"2014","journal-title":"J, Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.humimm.2023.110741_b0265","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jdermsci.2015.08.002","article-title":"Expression of IL-36 family cytokines and IL-37 but not IL-38 is altered in psoriatic skin","volume":"80","author":"Keermann","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.humimm.2023.110741_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109705","article-title":"The role of IL-37 in skin and connective tissue diseases","volume":"122","author":"Pan","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"13","key":"10.1016\/j.humimm.2023.110741_b0275","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133318","article-title":"The significance of IL-36 hyperactivation and IL-36R targeting in psoriasis","volume":"20","author":"Madonna","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.humimm.2023.110741_b0280","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/08916930500124072","article-title":"PD-1\/PD-L pathway and autoimmunity","volume":"38","author":"Okazaki","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.humimm.2023.110741_b0285","doi-asserted-by":"crossref","DOI":"10.1111\/odi.13344","article-title":"Evaluation of PD-L1, PD-L2, PD-1 and cytotoxic immune response in oral lichen planus","author":"Costa","year":"2020","journal-title":"Oral Dis."},{"issue":"1","key":"10.1016\/j.humimm.2023.110741_b0290","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/jaut.1999.0343","article-title":"CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry","volume":"14","author":"Ferenczi","year":"2000","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.humimm.2023.110741_b0295","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1074\/jbc.M706292200","article-title":"A novel mechanism for LSECtin binding to Ebola virus surface glycoprotein through truncated glycans","volume":"283","author":"Powlesland","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.humimm.2023.110741_b0300","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010075","article-title":"The next-generation immune checkpoint LAG-3 and its therapeutic potential in oncology: third time's a charm","volume":"22","author":"Lecocq","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.humimm.2023.110741_b0305","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF02788753","article-title":"Role of the CTLA-4 receptor in T cell activation and immunity. Physiologic function of the CTLA-4 receptor","volume":"18","author":"Scheipers","year":"1998","journal-title":"Immunol. Res."},{"issue":"5","key":"10.1016\/j.humimm.2023.110741_b0310","doi-asserted-by":"crossref","DOI":"10.3390\/biom10050750","article-title":"Galectins as checkpoints of the immune system in cancers, their clinical relevance, and implication in clinical trials","volume":"10","author":"Compagno","year":"2020","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.humimm.2023.110741_b0315","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/jdv.16780","article-title":"Expression of PD-1 and Tim-3 is increased in skin of patients with bullous pemphigoid and pemphigus vulgaris","volume":"35","author":"Ernst","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.humimm.2023.110741_b0320","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jid.2021.06.026","article-title":"Differential involvement of programmed cell death ligands in skin immune responses","volume":"142","author":"Tanaka","year":"2022","journal-title":"J. Invest. Dermatol."},{"issue":"11","key":"10.1016\/j.humimm.2023.110741_b0325","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.jid.2016.04.032","article-title":"The spectrum of mild to severe psoriasis vulgaris is defined by a common activation of IL-17 pathway genes, but with key differences in immune regulatory genes","volume":"136","author":"Kim","year":"2016","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.humimm.2023.110741_b0330","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jdermsci.2017.11.007","article-title":"The expression of mCTLA-4 in skin lesion inversely correlates with the severity of psoriasis","volume":"89","author":"Liu","year":"2018","journal-title":"J. Dermatol. Sci."},{"issue":"1","key":"10.1016\/j.humimm.2023.110741_b0335","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.clim.2009.11.008","article-title":"Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity","volume":"135","author":"Zhang","year":"2010","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2023.110741_b0340","article-title":"Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy","volume":"12","author":"Yang","year":"2021","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.humimm.2023.110741_b0345","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1385690","article-title":"Blockade of Tim-3 binding to phosphatidylserine and CEACAM1 is a shared feature of anti-Tim-3 antibodies that have functional efficacy","volume":"7","author":"Sabatos-Peyton","year":"2018","journal-title":"Oncoimmunology"},{"issue":"5","key":"10.1016\/j.humimm.2023.110741_b0350","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.4049\/jimmunol.175.5.2974","article-title":"Galectin-9 induces maturation of human monocyte-derived dendritic cells","volume":"175","author":"Dai","year":"2005","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.humimm.2023.110741_b0355","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/1346-8138.12884","article-title":"Elevated serum galectin-9 levels in patients with atopic dermatitis","volume":"42","author":"Nakajima","year":"2015","journal-title":"J. Dermatol."},{"issue":"9","key":"10.1016\/j.humimm.2023.110741_b0360","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.4049\/jimmunol.1901481","article-title":"Galectin-9 and VISTA expression define terminally exhausted T cells in HIV-1 infection","volume":"204","author":"Shahbaz","year":"2020","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2023.110741_b0365","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001849","article-title":"Galectin-9 expression defines exhausted T cells and impaired cytotoxic NK cells in patients with virus-associated solid tumors","volume":"8","author":"Okoye","year":"2020","journal-title":"J. Immunother. Cancer"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885923003762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885923003762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:59:39Z","timestamp":1759319979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885923003762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0198885923003762"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2023.110741","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The elevation of plasma galectin-9 levels in patients with psoriasis and its associations with inflammatory and immune checkpoint molecules in skin tissues","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2023.110741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.","name":"copyright","label":"Copyright"}],"article-number":"110741"}}